The FDA has approved checkpoint inhibitor cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma.
LAKE TAHOE, CALIF. – Children experience a wide range of cutaneous manifestations of immunosuppression.
Government and Regulations
It’s time to start counseling on sunscreen, waterborne illness, and mosquito avoidance.
Primary care providers should monitor disease progression in the skin and in the pulmonary, renal, cardiac, and gastrointestinal systems in...
A Danish cohort study found that HIV-positive patients are more likely to develop basal cell carcinoma and squamous cell carcinoma.
Veterans with skin cancer have seen improved access to Mohs micrographic surgery over the past 10 years, yet the challenges of travel distance and...
An unusual presentation highlighted the unique health maintenance challenges of reservist patients and the importance of a thorough history for...